AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
Jan 6, 2015
29828_dirs_2015-01-06_fb6b6a2f-86f6-4aa9-b061-d3390130e6b5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-01-02
Reporting Person: Whitley Richard James (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-01-02 | Common Stock | M | 5000 | $26.9900 | Acquired | 20641 | Direct |
| 2015-01-02 | Common Stock | S | 4000 | $95.0359 | Disposed | 16641 | Direct |
| 2015-01-02 | Common Stock | S | 1000 | $95.9560 | Disposed | 15641 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-01-02 | Non-Qualified Stock Option (Right to Buy) | $26.9900 | M | 5000 | Disposed | 2018-07-30 | Common Stock (5000) | Direct |
Footnotes
F1: The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: Options are 50% vested on the first anniversary of the date of grant and 100% vested on the second anniversary of the date of grant.
F3: Sale prices reported for the transactions reported here range from $94.61 to $95.49. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $95.61 to $96.29. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.